Lastest News
Discover how Southern California Neurology Consultants—led by Dr. Arbi G. Ohanian in Pasadena, CA—combines rapid feasibility, operational precision, and compassionate care to drive neurological …
February 13, 2025
We are excited to announce the newest addition to Profound Research’s executive leadership team, John D. Williford, Esq., who joins us as General Counsel. …
January 22, 2025
At Profound Research, every team member plays a crucial role in advancing our mission of improving lives through advanced therapeutic options. Today, we’re excited …
November 18, 2024
At Profound Research, our commitment to quality goes beyond compliance; it's a core value that guides our mission to improve lives through advanced therapeutic …
November 14, 2024
As we continue our celebration of World Quality Week, we’re excited to spotlight one of the talented team members who drives Profound Research’s commitment …
November 13, 2024
As Profound Research celebrates World Quality Week, we’re excited to highlight one of our Quality Team members whose dedication exemplifies our mission and values. …
November 12, 2024
Alzheimer’s disease (AD) is a major global health issue, with over 55 million people affected worldwide. Early detection of AD is challenging, as there …
September 20, 2024
Profound Research (Profound), a leading clinical site network, and Cardiology and Vascular Associates (CAVA), a prominent cardiology and vascular medicine group, have announced a …
August 6, 2024
Profound Research, a leading clinical trial site network, today announced the key leadership appointment of Michael Shipton as Chief Commercial Officer, a move aimed …
August 6, 2024
Celebrating a Milestone in Alzheimer's Treatment Profound Research extends our heartfelt congratulations to our sponsor partner, Eli Lilly, on the recent approval of Kinsunla™ …
July 3, 2024
